🏥 治験ポータル
← 治験一覧に戻る

アジアにおける肝細胞癌登録:INSIGHTレジストリ

基本情報

NCT ID
NCT03233360
ステータス
完了
試験のフェーズ
-
試験タイプ
観察
目標被験者数
2,533
治験依頼者名
National Cancer Centre, Singapore

概要

The INSIGHT ('Insight into Real-world Practice of Management of HCC in Asia-Pacific') registry is designed as a multi-centre longitudinal cohort study of patients diagnosed with HCC between 1st January 2013 and 31st December 2019 in nine countries (i.e., South Korea, Taiwan, Thailand, Japan, China, Hong Kong, Australia, New Zealand and Singapore). Approximately 30% of the sample size will be identified retrospectively and 70% will be identified prospectively from the start date of the registry (October 2016), with an even distribution of consecutively diagnosed patients within the different years.

対象疾患

Hepatocellular Carcinoma

実施施設 (4)

Kyorin University School of Medicine

Mitaka-shi, Tokyo, Japan

PFCJAPANCLINIC新庄健康長寿医療センター

Chūōku, Tokyo, Japan

近畿大学東洋医学研究所附属診療所

Ōsakasayama, Osaka, Japan

University of Tokyo

Tokyo, Japan